Interleukin 25

From WikiMD's WELLNESSPEDIA

Interleukin 25 (IL-25) is a cytokine that belongs to the IL-17 family. It is also known as IL-17E. IL-25 is produced by Th2 cells, mast cells, and eosinophils, and it plays a crucial role in the immune response, particularly in the context of allergic reactions and autoimmune diseases.

Structure[edit]

IL-25 is a member of the IL-17 family, which is composed of six cytokines (IL-17A to IL-17F). IL-25 (IL-17E) is structurally distinct from the other members of the family. It is a 177-amino acid protein with a molecular weight of approximately 20 kDa.

Function[edit]

IL-25 induces the production of other cytokines such as IL-4, IL-5, and IL-13 in target cells, which are involved in the Th2 immune response. This response is characterized by the activation of eosinophils, the production of IgE, and the development of airway hyperreactivity, which are all key features of allergic inflammation.

Role in Disease[edit]

IL-25 has been implicated in several diseases, including asthma, atopic dermatitis, and eosinophilic esophagitis. It has also been associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

Therapeutic Potential[edit]

Due to its role in the immune response, IL-25 is being investigated as a potential therapeutic target for the treatment of allergic and autoimmune diseases. Inhibiting the activity of IL-25 may help to reduce the severity of these conditions.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.